In the News
Russo Partners works at the intersection of science, medicine, and media. The stories below reflect the conversations we help shape covering breakthroughs in biopharma, digital health, healthcare, and beyond.
Forbes
|
December 19, 2025
This Company’s Drug May Help Regenerate Injured Spinal Cord
Every year, around 18,000 Americans will suffer a traumatic spinal cord injury. This can lead to a number of complications,…
For more
STAT News
|
December 16, 2025
Ambros Therapeutics, Ramaswamy’s latest startup, launches with plans for pain treatment
Ramaswamy’s latest startup, Ambros Therapeutics, launched Tuesday with plans to develop a treatment for a rare form of the chronic…
For more
BioXconomy
|
December 12, 2025
Reflecting on the biotech funding landscape of 2025 and looking ahead to 2026
Ahead of JP Morgan Healthcare Conference and Biotech Showcase, industry leaders gathered to reflect on the year’s developments and share…
For more
New York Post
|
November 7, 2025
My infant son died of a rare disorder — I wish his doctors had run this cheap test sooner
Jordan Kruse realized something was wrong with her newborn, Pruitt, hours after bringing him home from the hospital last year….
For more
BioWorld
|
November 4, 2025
Scientists rehabilitate disease-causing T cells into tolerance builders
What one high-school student learned from Ben Abercrombie, who didn’t let a catastrophic injury hold him back from achieving his…
For more
Rolling Stone
|
October 30, 2025
He Was Paralyzed Playing Football. His Strength Inspired Me to Take Action
For 75 years, the standard tools for autoimmune disease have consisted of steroids, cytotoxics and broad biologics that tamp down…
For more
Upcoming Events
Our team is active across the industry year-round. Find us at these upcoming conferences and events.
